Clinical Trials Browser

Completed × Has results × GSK2636771 × Clear all

NCT02215096 2020-10-22

Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer

Phase 1 Completed

37 enrolled 26 charts

Neoplasms